首页 | 本学科首页   官方微博 | 高级检索  
     


Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or older
Authors:Michelle R. Rowland  Jamie L. Lesnock  Coreen Farris  Joseph L. Kelley  Thomas C. Krivak
Affiliation:1. Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA;2. RAND Corporation, Pittsburgh, PA;3. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Western Pennsylvania Hospital, Pittsburgh, PA;4. Mid Atlantic Gynecologic Oncology of Mon General Hospital, Morgantown, WV
Abstract:
Keywords:cost comparisons   neoadjuvant chemotherapy   ovarian cancer   primary debulking surgery
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号